Gut dysbiosis and neuroimmune responses to brain infection with Theiler’s murine encephalomyelitis virus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gut dysbiosis and neuroimmune responses to brain infection with Theiler’s murine encephalomyelitis virus

Published:2017-03-14 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Carrillo-Salinas F. J.,Mestre L.,Mecha M.,Feliú A.,del Campo R.,Villarrubia N.,Espejo C.,Montalbán X.,Álvarez-Cermeño J. C.,Villar L. M.,Guaza C.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep44377.pdf

Reference68 articles.

1. Lassmann, H. et al. Pathology and disease mechanisms in different stages of multiple sclerosis. J Neurol Sci 333, 1–4 (2013).

2. Ferguson, B., Matyszak, M. K., Esiri, M. M. & Perry, V. H. Axonal damage in acute multiple sclerosis lesions. Brain 120 (Pt 3), 393–399 (1997).

3. Trapp, B. D. et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338, 278–285 (1998).

4. Koch, M. W., Metz, L. M., Agrawal, S. M., Yong, V. W. & Lipton, H. L. Environmental factors and their regulation of immunity in multiple sclerosis J Neurol Sci 324, 10–16 (2013).

5. Wang, Y. & Kasper, L. H. The role of microbiome in central nervous system disorders. Brain Behav Immun 38, 1–12 (2014).

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Theiler’s murine encephalomyelitis virus in treatment of multiple sclerosis;Frontiers in Microbiology;2024-06-26

2. Gut microbiota in multiple sclerosis and animal models;The FEBS Journal;2024-05-30

3. Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis;Gut Microbes;2023-11-18

4. Role of the intestinal microbiota in the pathogenesis of multiple sclerosis. Part 2. Gut microbiota as a predisposition factor for the multiple sclerosis development;Medical academic journal;2023-05-22

5. Gut Microbiota Might Act as a Potential Therapeutic Pathway in COVID-19;Current Pharmaceutical Biotechnology;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3